Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer Cells
Antioxidants & Redox Signaling · 2023
DOI: 10.1089/ars.2022.0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2023. Verfasst von Yuki Ohkawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Aims
The anticancer function of superoxide dismutases (SODs) is still controversial. SOD3 is an extracellular superoxide dismutase and contains a single N -glycan chain. The role played by the N -glycosylation of SOD3, as it relates to lung cancer, is poorly understood. For this, we performed the structural and functional analyses of the N -glycan of SOD3 in lung cancer.
Results
We report herein that the fucose structure of the N -glycan in SOD3 was increased in the sera of patients with lung cancer. In cell lines of non-small lung cancer cell (NSCLC), we also found a high level of the core fucose structure in the N -glycan of SOD3, as determined by lectin blotting and mass spectrometry analysis. To address the roles of the core fucose structure of SOD3, we generated FUT8 (α1,6-fucosyltransferase) gene knockout A549 cells. Using these cells, we found that the core fucose structure of SOD3 was required for its secretion and enzymatic activity, which contributes to the suppression of cell growth of NSCLC cells. Innovation: The core fucosylation is required for the secretion and enzymatic activity of SOD3, which contributes to anti-tumor functions such as the suppression of cell growth of NSCLC.
Conclusion
The N -glycans, especially those with core fucose structures, regulate the anti-tumor functions of SOD3 against NSCLC. Antioxid. Redox Signal . 38, 1201–1211.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka, Japan.
- Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, Osaka University, Osaka, Japan.
- Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
- Institute for Glyco-core Research (iGCORE), Gifu University, Gifu, Japan.
- Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Japan.
- Division of Structural Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
ORCID-Profile: Yuki Ohkawa, Kento Maeda
Zitieren
APA
Ohkawa, Y., Kitano, M., Maeda, K., Nakano, M., Kanto, N., Kizuka, Y., Seike, M., Azuma, A., Yamaguchi, Y., Ookawara, T., Miyoshi, E., & Taniguchi, N. (2023). Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer Cells. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2022.0010
Vancouver
Ohkawa Y, Kitano M, Maeda K, Nakano M, Kanto N, Kizuka Y, et al. Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer Cells. Antioxidants & Redox Signaling. 2023. doi:10.1089/ars.2022.0010
BibTeX
@article{Ohkawa2023,
author = {Ohkawa, Yuki and Kitano, Masato and Maeda, Kento and Nakano, Miyako and Kanto, Noriko and Kizuka, Yasuhiko and Seike, Masahiro and Azuma, Arata and Yamaguchi, Yoshiki and Ookawara, Tomomi and Miyoshi, Eiji and Taniguchi, Naoyuki},
title = {Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer Cells},
journal = {Antioxidants & Redox Signaling},
year = {2023},
doi = {10.1089/ars.2022.0010}
}
EUVIMED